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Intracellular Accumulation of Gold 
Nanoparticles Leads to Inhibition 
of Macropinocytosis to Reduce the 
Endoplasmic Reticulum Stress
Nuray Gunduz1,*, Hakan Ceylan2,*, Mustafa O. Guler1 & Ayse B. Tekinay1,3
Understanding the toxicity of nanomaterials remains largely limited to acute cellular response, i.e., 
short-term in vitro cell-death based assays, and analyses of tissue- and organ-level accumulation 
and clearance patterns in animal models, which have produced very little information about how 
these materials (from the toxicity point of view) interact with the complex intracellular machinery. 
In particular, understanding the mechanism of toxicity caused by the gradual accumulation of 
nanomaterials due to prolonged exposure times is essential yet still continue to be a largely unexplored 
territory. Herein, we show intracellular accumulation and the associated toxicity of gold nanoparticles 
(AuNPs) for over two-months in the cultured vascular endothelial cells. We observed that steady 
exposure of AuNPs at low (non-lethal) dose leads to rapid intracellular accumulation without causing 
any detectable cell death while resulting in elevated endoplasmic reticulum (ER) stress. Above a certain 
intracellular AuNP threshold, inhibition of macropinocytosis mechanism ceases further nanoparticle 
uptake. Interestingly, the intracellular depletion of nanoparticles is irreversible. Once reaching the 
maximum achievable intracellular dose, a steady depletion is observed, while no cell death is observed 
at any stage of this overall process. This depletion is important for reducing the ER stress. To our 
knowledge, this is the first report suggesting active regulation of nanoparticle uptake by cells and the 
impact of long-term exposure to nanoparticles in vitro.
Advances in nanotechnology have resulted in the development of a large variety of engineered nanomaterials for 
numerous applications in chemistry, engineering and biomedical sciences1–4. However, the prospect of ubiquitous 
use of nanomaterials has also raised concerns regarding the safety of these materials5, so the assessment of their 
potential toxicities has emerged as a major research area1. The toxicity of nanomaterials is difficult to predict and 
stems from a combination of their physicochemical properties, including size6,7, morphology7, surface chemis-
try8, agglomeration/aggregation state9, solubility10 and biological milieu11, and may also vary depending on the 
cell types involved12–14. Therefore, both the short- and long-term effects of engineered nanomaterials should be 
investigated in great detail to eliminate the possibility of unforeseen health hazards prior to their use in industrial 
and, in particular, biomedical applications. On the other hand, the mainstream strategy for understanding the 
toxicity of nanomaterials remained largely limited to short-term cell viability-based assays in vitro and analyses of 
tissue-level accumulation and clearance patterns in animal models, which have produced very little information 
on how these materials interact adversely with profoundly complex cellular machinery15–17. Few previous reports 
towards this scope were mostly focused around the effects of acute toxic doses on cells occurring only in a few 
days, without realizing the toxicity occurring as a result of the intracellular accumulation of nanomaterials after 
prolonged exposure times, which is regarded vital, yet still continues to be an unexplored territory18,19.
Engineered AuNPs attract special attention because of their rather well-established fabrication methods, low 
variance in size and shape, convenient means of surface functionalization, high chemical stability, inertness, 
relative biocompatibility and low acute toxicity20. Consequently, AuNPs are now being used with increasing 
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frequency in photothermal therapy21, targeted drug22 and gene delivery23, magnetic resonance imaging and other 
biomedical applications, and are also considered therapeutic agents by themselves (e.g. for rheumatoid arthri-
tis)24. Immediately following their entry into biological systems, AuNPs interact with various local biomacro-
molecules to assemble a dynamic protein corona on their surfaces. The formation of this layer has significant 
effect on the cellular uptake11,25,26, targeting ability27, accumulation and toxicity of nanoparticles in living systems, 
and depends strongly on the composition of the environment encountered by the material. The long-term risk 
assessment of nanomaterials is typically done using animal models, which assess systemic toxicity and accumula-
tion in organs rather than the behaviors undertaken by individual cells to reduce the local concentration of toxic 
material. In contrast, cell culture-based toxicity models are generally used for assessment of short-term exposure, 
while long-term observation is difficult because the high proliferative capacity of cells imposes constraints on 
maximum culture time. Thus, there is a detachment between in vitro and in vivo models of toxicity assessment 
and a strong need for further research into the cellular processes that are altered during long-term nanoparticle 
exposure. In addition, studies that do consider long-term cellular exposure tend to utilize the occupational expo-
sure model28–32, and more studies are necessary to understand long-term nanoparticle toxicity upon continuous 
exposure.
In this work, we show the impact of slow, long-run intracellular accumulation of AuNPs on the nanoparticle 
uptake dynamics and associated intracellular stresses in vitro. Continuous exposure to AuNPs nanoparticles in 
low doses provides a reliable window for dissecting the toxicity stemming from the long-term exposure to nan-
oparticles, from acute toxicity resulting from high-dose exposure. The in vitro study model described herein is 
very practical and informative for the future studies regarding the accumulation of a wide scope of engineered 
nanomaterials.
Results and Discussion
Characterization of AuNPs. Citrate-capped AuNPs with ca. 12 nm size (12.2 ± 1.0 nm by transmission 
electron microscopy and 11.8 ± 2.3 nm by dynamic light scattering) were synthesized by using Turkevich method 
(Fig. 2B and Figure S1A). The UV-Vis spectrum of citrate-capped AuNPs displayed a distinct surface plasmon 
resonance peak (SPR) at 518 nm (in ultrapure water). The location of SPR signal is informative about the elec-
tronic properties of the surrounding medium and the state of nanoparticle aggregations that may potentially 
result from the formation of surface corona from macromolecular species. A slight red shift in the absorption 
spectrum of AuNPs when placed in fetal bovine serum suggested the formation of a corona on the nanoparticle 
surface that is caused by the displacement of weakly-bound citrate ions with multivalent macromolecules present 
in the serum (Fig. 2C, Figure S1B,C and D). A concomitant increase in zeta potential (from − 30 mV to − 10 mV) 
was also observed, further suggesting the alteration in the surface chemistry of the nanoparticles following intro-
duction into the biological environment. A fluctuation in zeta potential was also observed in time-dependent 
measurements, which was attributable to the mobile elements of the dynamic corona (Figure S1E). Such altera-
tions on the surface chemistry of the AuNPs suggest a new biological identity (in addition to its chemical identity 
determined by its size and surface characteristics) that could influence its interactions with the cells. The sig-
nificance of this biological identity was further observed in the viability experiments in order to determine the 
exposure dose of AuNPs for accumulation studies.
Cytotoxicity and internalization of AuNPs. Human umbilical vein endothelial cells (HUVECs) were 
cultured in serially-diluted concentrations of nanoparticles in 5% or 10% serum-containing media (Fig. 2D,E 
and F). In 5% serum containing medium AuNPs at 8 μ g/mL and below concentrations were found to have no 
detrimental effect on the cell viability after 24 h (Fig. 2E). Higher concentrations, however, resulted in significant 
decrease in the cell viability because of increased nanoparticle uptake (Fig. 2E, Figures S3 and S4). In 10% serum 
containing medium, cell viability was ca. 80% at 64 μ g/mL administered dose of AuNPs, whereas it was found 
this ca. 40% in 5% serum containing medium (Fig. 2D and E). Interestingly, the acute lethality of AuNPs was 
Figure 1. Schematic illustration of the long-term AuNP accumulation model. Endothelial cells (HUVECs) 
are cultivated under standard growth conditions in tissue culture plates. Additionally, their culture media were 
supplemented with AuNPs at a constant dose of 8 μ g/mL, which is just below the acute lethal level. Based on 
this model, cells are expected to uptake AuNPs during the growth phase of the cell cycle, and then, typically, 
undergo mitosis and presumably halve their nanoparticle content into each of the offspring. Nevertheless, the 
continuous exposure to the nanoparticles in the medium leads to steady intracellular accumulation over time. 
In the early term, i.e., approximately first two weeks, cells are observed to steadily accumulate AuNPs until a 
maximum peak level followed by a steady decrease for the next following weeks approaching to the ground zero 
level.
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found to be highly dependent on the concentrations of the biomacromolecules present in the medium, especially 
at elevated AuNP concentrations. Therefore, interactions at the cell-nanoparticle interface appear to be strongly 
influenced by the altered biological identity of the AuNPs. It is well-known that the high surface energy of AuNPs 
allow unfolding of coronal proteins, which exposes previously unavailable domains to the biological environ-
ment33. The cellular uptake of nanoparticles, a very initial step towards the cytotoxic response, may then change 
considerably depending upon the biological environment and on the concentration of the biomacromolecular 
components in which the nanoparticles are presented11. Indeed, we observed that the amount of nanoparticles 
taken up by cells is considerably higher when cells were exposed to the nanoparticles in 5% serum, which is in 
parallel with the higher cell death caused by AuNPs in 5% serum (Fig. 2E). Consequently, the altered uptake and 
viability are likely to be caused by the altered characteristics of the protein corona, which is tremendously influ-
enced by the concentration of the macromolecular species inside serum even though, both media are the same.
In vitro long-term accumulation of AuNPs. In the next step, we investigated the intracellular accumu-
lation pattern of AuNPs in cultured HUVECs. Due to elevated uptake of AuNPs, from here on, the rest of the 
accumulation studies were carried out in 5% serum containing medium. HUVECs were seeded and exposed to 
8 μ g/mL AuNPs; after reaching ca. 90% confluency, they were subcultured and re-seeded again. This process was 
repeated over time to obtain long-term accumulation model (see Fig. 1 and experimental section). In order to dis-
sect the impact of long-term nanoparticle accumulation from the acute toxic effects, the AuNPs were introduced 
to cells below the acute lethal dose, which was determined as 8 μ g/mL from the viability assay (Fig. 2E,F). During 
the first two weeks, AuNPs rapidly accumulated inside HUVECs (Fig. 3A). Intracellular accumulation was fur-
ther evidenced by silver staining, which enables visualization of the AuNPs under light microscope. Independent 
repeats of this experiment showed that this initial accumulation period could extend until 20 days, with the 
same pattern in each repeat. Nonetheless, no further accumulation was observed after this period. Strikingly, the 
peak accumulation is followed by a steady decline in the amount of intracellular AuNPs (Fig. 3B). Furthermore, 
we observed repeatable fluctuations in the intracellular AuNPs amount even though the overall trend is down, 
during the decline period (Fig. 3A). There are two possible explanations for the decline in the intracellular AuNP 
Figure 2. Characterizations, cytotoxicity, and protein corona effects on the internalization of AuNPs. 
Transmission electron micrograph (Scale bar 20 nm) (A) and particle size distribution of AuNPs (B). UV-Vis 
spectra of AuNPs in concentrations ranging from 64 μ g/mL in 5% FBS-containing media and in water (C). 
Dose-dependent cytotoxicity in HUVECs after 24 h of AuNPs exposure in 10% FBS DMEM (D) and 5% FBS 
DMEM (E) (Error bars show SEM, two independent experiments were repeated with n = 4 in 10% FBS DMEM 
cytotoxicity and n = 8 in 5% FBS DMEM cytotoxicity experiments. One-way ANOVA with Tukey’s Multiple 
Comparison Test was used to show statistical significance at ***p < 0.001 and **p < 0.01). Relative uptake of  
8 μ g/mL AuNPs exposed in 10% FBS DMEM and 5% FBS DMEM in HUVECs after 4 h of incubation (F) (Error 
bars show SEM, two independent experiments were repeated with n = 3 in each experiment. Student’s t-test was 
used to show statistical significance at **p < 0.01).
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accumulation: (a) the uptake of new AuNPs is inhibited by inhibiting the endocytosis process, or (b) AuNPs 
inside the cells are actively transported from the cells to the outside environment. There are few reports on the 
exocytosis of surface-functionalized AuNPs34–36 despite the fact that inhibition of the uptake process has not been 
previously reported.
Endocytosis and exocytosis behavior of AuNP accumulated cells. To understand endocytosis and 
exocytosis behavior, we first investigated the mechanism of AuNPs uptake by HUVECs. Although the uptake 
mechanisms of bare and surface-functionalized AuNPs in a variety of sizes and shapes have been characterized 
in the literature, their internalization is difficult to generalize and may depend on processes such as macropi-
nocytosis37, phagocytosis38,39, receptor mediated endocytosis7 (clathrin- or caveolae-mediated endocytosis) and 
transcytosis40. Therefore, three of these major pathways (macropinocytosis, caveolae-mediated endocytosis, and 
clathrin-mediated endocytosis) were blocked by inhibitor treatment to observe whether AuNP uptake depended 
on any of these mechanisms (Table S1). The uptake of AuNPs was observed to greatly (ca. 30%) diminish follow-
ing the inhibition of macropinocytosis while this decrease was not as pronounced after inhibition of caveolae- or 
clathrin-mediated endocytosis (Figure S2). This result suggests that AuNPs were predominantly entering into 
HUVECs via macropinocytosis. Gulsuner et al, showed that MDP-AuNPs which contains RGD sequence as tar-
geting moiety enters into breast cancer cells via both clathrin-mediated endocytosis and macropinocytosis path-
way37. The cells might use non-specific entry routes for endocytosis of non-functionalized AuNPs. Therefore, lack 
of targeting moiety might activate macropinocytosis pathway for nanoparticle endocytosis.
In order to understand if any of these major routes of uptake is impaired during the accumulation process, 
we investigated the endocytosis competency of cells on day 23, one of the early days of the decline in the intra-
cellular AuNP amount (Fig. 3A). For this purpose, cells were incubated with fluorophore-conjugated molecules 
that enter cells through specific endocytosis pathways and then checked if these molecules are inside the cells. 
Among these molecules, choleratoxin enters cells through caveola-mediated endocytosis, transferrin enters 
via clathrin-mediated endocytosis, and dextran enters via macropinocytosis. While cholera toxin and transfer-
rin entries were observed in both AuNP (+ ) and AuNP (− ) groups, dextran entry was observed only in the 
AuNP (− ) group, indicating that macropinocytosis, the main route of AuNP uptake, ceased altogether (Fig. 5). 
Nevertheless, the complete inhibition of macropinocytosis is far from explaining the drastic decrease in the intra-
cellular AuNP. As a result, we further explored a potential role for exocytosis for the active transport of AuNPs 
out of the cells, however, we detected no evidence that exocytosis plays a significant role for the removal of AuNPs 
inside the cells (Figure S5). It is likely that cell division plays a predominant role for dilution of AuNPs in the 
new offspring cells41. Because the macropinocytosis is inhibited, these two effects are combined to culminate in a 
gradual decrease of AuNPs inside the cells.
Determination of cellular stress during long-term accumulation. Engineered nanomaterials bound 
to biomacromolecules can cause conformational changes42 in the structure of proteins, which might result in 
ER stress through the unfolded protein response (UPR), and trigger oxidative stress10 through ROS formation. 
ER stress is generally considered an adaptive reaction of cells to external stress, and serves as a survival mecha-
nism. This complex stress response is mediated by several molecules, such as PKR-like ER kinase (PERK), acti-
vated transcription factor 6 (ATF6), inositol-requiring enzyme 1 (IRE1), and spliced X box-binding protein 1 
(sXBP1)43. IRE1 is activated in response to accumulation of unfolded proteins, and acts as a site-specific endonu-
clease splicing out a 26-nucleotide intron in XBP1 mRNA. Spliced XBP1 mRNA is translated to produce spliced 
XBP1 protein, which is a transcription factor and one of the key regulators of the protein-folding capacity of 
the cells and ER homeostasis43. Therefore, cellular levels of XBP1 and its spliced form, sXBP1 were monitored 
Figure 3. In vitro long-term accumulation of AuNPs in HUVECs. The amount of internalized AuNPs in 
HUVECs quantified from the data measured by ICP-MS at each passage and its normalization to cell number. 
The number of AuNPs is expressed as AuNPs per cell (A). Silver staining of cells at different accumulation time 
points (days 7, 14, 21, and 28) (B). Scale bars are 20 μ m.
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through polyacrylamide gel electrophoresis (PAGE) and qRT-PCR to evaluate ER stress at different accumulation 
time points (Table S2). Interestingly, a slight sXBP1 band was observed at the point of highest accumulation (day 
12), which became more pronounced at day 16 in the AuNP (+ ) group but not observed in the AuNP (− ) group 
(Fig. 6A). Moreover, there are also slight bands at day 28 and 30 in the AuNP (+ ) group but not seen in the AuNP 
(− ) group. This result was also confirmed using only the sXBP1 primer in qRT-PCR, where a sharp peak with 
significant increase of 201.94 ± 6.29 of AuNP (− ) group was seen at day 16. sXBP1 expression was statistically 
significant to other AuNP accumulated days (Fig. 6B). Expression profile of sXBP1 correlates with accumulation 
of AuNPs inside the cells, which suggests that peak accumulation occurs at day 12 due to slight ER stress, while 
increased ER stress at day 16 triggers a decline in AuNP accumulation. Under prolonged ER stress, cells typically 
ignite a specific cell death program, apoptosis44. At the end of 57 days of accumulation, both viability and ROS 
levels in AuNP (+ ) and AuNP (− ) cells were comparable, indicating that long-term accumulation of AuNPs 
did not induce cell death and ROS formation (Figs 4A and 5C). Thus, it is likely that cells exposed to AuNPs for 
longer periods develop a survival mechanism via short-term on/off of ER stress followed by inhibition of their 
macropinocytosis pathway, and thereby control the intracellular concentration of AuNPs. A link was previously 
established between ER stress and endocytosis inhibition in the literature45, and this cooperative mechanism 
might possibly serve to control intracellular concentration of engineered nanomaterials. On the other hand, the 
proliferative capacity of cells in AuNP (+ ) group decreased slightly but significantly when compared to AuNP (− ) 
cells (Fig. 4B). One week exposure of low dose of citrate-capped AuNPs (~18 nm in diameter) has previously been 
reported to trigger a similar decrease in cell proliferation without compromising cell viability46.
Conclusion
In this work, we show the toxic impact of chronic exposure and accumulation of AuNPs on endothelial cells. Even 
though AuNPs are largely considered “non-toxic” and “safe” based on the short-term exposure assays, we realize 
that their long-term interaction with the cellular machinery is highly complex and creates major challenges for 
cells to eliminate the stress caused by its accumulation. To elucidate this, we designed a new in vitro accumulation 
model, which enables assessment at non-lethal exposure doses over an extended period of time. This platform 
emulates certain aspects of in vivo exposure conditions as well as utilizes a simple-to-implement cell culture 
model that can be used to directly analyze the long-term effects of other types of nanoparticles accumulated 
in the cellular environment. The information deduced from the accumulation experiments demonstrates the 
strength of the model, thereby paving the way of improving risk assessment methods and extending protocols for 
the development of alternate cell-based models to better understand the nanomaterial safety and the associated 
risks. Nevertheless, there are still important challenges and questions that remain to be addressed for the optimal 
evaluation of long-term nanomaterial toxicity. For example, a more robust method could be developed where 
cell division and proliferation is inhibited, so the effect of cell division on diluting the intracellular nanoparticles 
is eliminated. However, the challenge here is to keep cells alive and healthy under the cell cycle arrest conditions 
for extended periods of time. Ultimately, this and other complementing in vitro toxicity models are expected 
Figure 4. Cellular response to long-term accumulation of AuNPs. Cytotoxicity of AuNPs after 57 days was 
assessed with Live/Dead (Calcein Am/Ethidium homodimer staining) and MTT assay. Live cells were stained 
green and dead cells were stained red. Student t-test was used for statistical analysis and significance was 
not found (A). Proliferation of cells after 49 days of accumulation was assessed with Click-iT EdU assay. The 
nuclei of proliferating cells were stained green. Student t-test shows statistical significance with *p < 0.05 (B). 
Error bars show SEM in all graphics, experiments were repeated with n = 3 in both viability and proliferation 
experiments. Scale bars are 200 μ m in all images.
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to provide invaluable mechanistic information about cell-nanomaterial interactions at the molecular level as 
well as enormous practical flexibility for experimental setup design, thereby significantly reducing the need for 
animals-based models and number of animals being sacrificed.
Experimental Section
Chemicals and Reagents. Gold (III) chloride trihydrate (HAuCl4.H2O), 2′ , 7′ dichlorofluorescein diacetate, 3-(4, 
5-dimethylazol-2-yl)-2, 5-diphenyl-tetrazolium bromide (MTT) kit, Nystatin, Amiloride hydrochloride hydrate, 
Chlorpromazine hydrochloride, Silver Enhancer Kit SE-100, hydrocholoric acid fuming 37%, and Nitric acid > 
65% were purchased from Sigma-Aldrich Chemical Co. Ethidium homodimer, Calcein Am, Click-iT EdU assay, 
TRIzol, Alexa Fluor 488 conjugated Cholera toxin subunit B (recombinant), Fluorescein conjugated Dextran 
(10000 MW) and Alexa Fluor 488 conjugated Transferrin from human serum were purchased from Invitrogen 
(C34775, D1820, and T13342). All cell culture materials were also purchased from Gibco, Invitrogen. Sodium cit-
rate tribasic were obtained from Codex, Carlo Erba. Amicon® Ultracel centrifugal falcons were purchased from 
Millipore. Ultrapure water (18.2 MΩ) was obtained from a Sartorios arium® Lab Water System.
Synthesis of AuNPs. All glassware was carefully cleaned with aqua regia (3:1 mixture of hydrochloric and 
concentrated nitric acids), and rinsed with distilled water several times before use. AuNPs with 12-nm diameter 
were synthesized according to the previously published Turkevich protocol47. Briefly, 100 mL of HAuCl4 (1 mM) 
in water was boiled under stirring, and 10 mL of sodium citrate trihydrate solution (38.8 mM) was added rapidly 
to the chloride solution, which resulted in a change in solution color from pale yellow to deep red.
UV-Vis Spectroscopy and Transmission Electron Microscopy. UV-Vis spectra of AuNP solutions 
were measured using a SpectraMax M5 Multi-Mode Microplate Reader. Spectra of freshly prepared AuNPs and 
water (for baseline subtraction) were collected using quartz cuvettes with 1 cm optical path lengths and in a 
250–750 nm range with 2 nm increments. Structural characterization of the AuNPs was performed using a FEI 
Tecnai G2 F30 transmission electron microscope (TEM) at 300 kV. TEM samples were prepared on a fine mesh 
Cu grid by incubating a drop of AuNP solution for 5 min, washing with a drop of distilled water for 2 min and 
repeating these steps for two more times prior to drying. Individual particle sizes were measured using ImageJ 
(NIH) software. After the characterization of the nanoparticles by TEM and UV-Vis spectroscopy, their initial 
concentration was calculated by using previously established theoretical calculations48. The nanoparticles were 
then concentrated by using Amicon® Ultracel centrifugal falcons (10 K) at 6000 rpm for 5 min (repeated multiple 
times for required concentrations).
Dynamic Light Scattering (DLS) and Zeta Potential Measurements. DLS measurements were car-
ried out using a Malvern NanoZS Zetasizer at room temperature. Auto-correction was done as the average of 
three runs of 10 s each (Malvern Instruments, Southborough, MA).
Figure 5. Uptake profile of HUVECs (at day 23) incubated with fluorescence-labeled compounds that enter 
cells through specific endocytosis pathways. Cholera toxin enters through caveolin-mediated endocytosis, 
dextran enters through macropinocytosis, and Transferrin enters through clathrin-mediated endocytosis. Scale 
bars are 10 μ m.
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Cell Culture and Maintenance. Human umbilical cord vein endothelial cells (HUVECs) were donated by 
Yeditepe University, Istanbul, Turkey. HUVECs were purified as described49 and were characterized by staining 
with CD34, CD31, and CD90 surface markers. These cells were found to be positive for CD31 and CD34 but 
negative for CD90. HUVECs were cultured in a humidified, 37 °C, 5% CO2 incubator using 75 cm2 polystyrene 
cell culture tissue flasks containing Low Glucose Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 5% or 10% heat inactivated fetal bovine serum (FBS, Gibco), 1% penicillin/streptomycin (P/S) and 2 mM 
L-glutamine. Passaging of cells was performed at cell confluency between 90 to 100% using trypsin/EDTA. Cells 
were diluted 1:4 for subculturing.
Cell Viability and Proliferation. HUVECs were seeded at a density of 7.5 × 103 cells/well in a 96-well plate. 
After 4 h of incubation, media were removed and replaced with either 5% FBS or 10% FBS DMEM containing 
AuNPs at concentrations ranging from 0.5 μ g/mL to 64 μ g/mL, and cells were incubated for 24 h at 37 °C in a 
humidified incubator with 5% CO2. At the end of the exposure period, the toxicity of AuNPs was assessed by a 
standard colorimetric cellular viability assay, in which 3-(4,5-dimethylazol-2-yl)-2,5-diphenyl-tetrazolium bro-
mide (MTT) dye is converted to insoluble purple formazan crystals and metabolic activity is evaluated through 
absorbance measurements at 570 nm using a SpectraMax microplate reader (Molecular Devices, Sunnyvale, CA). 
All experiments were performed in quadruplicate and with three independent repeats.
Proliferative cells were determined using Click-iT EdU assay (Molecular Probes). HUVECs were incubated 
with a nucleoside analogue of thymine, EdU (5-ethynyl-20-deoxyuridine), in the culture medium. EdU is incor-
porated into DNA during the synthesis phase (S phase) of the cell cycle, and hence enables direct quantification 
of proliferation. HUVECs were seeded on 15 mm cover glasses at a density of 2.5 × 104 cells/glass. After 8 h of 
incubation, one half of the medium was replaced with 20 μ M EdU-containing fresh media supplemented with 5% 
FBS. Cells were then post-incubated for 48 h for the incorporation of the thymine analogue to DNA. Following 
post-incubation, cells were fixed with 4% paraformaldehyde, permeabilized with 0.5% Triton-X, and treated with 
Alexaflour-488 conjugated azide as recommended by the supplier. Proliferative cells were imaged by fluorescent 
microscopy. Stained cell nuclei were counted with ImageJ (NIH) software. The average counts of stained cell 
nuclei were used to evaluate the relative proliferative cell numbers. Both viability and proliferation results were 
normalized to non-treated control group.
In Vitro Long-term Accumulation Model. Following the assessment of cell viability, a non-toxic dose of 
8 μ g/mL was chosen for long-term accumulation experiments. HUVECs were seeded in 6 well plates at a density 
of 1 × 105 cells/well, and exposed to AuNPs after their attachment to well surfaces (~4 h). HUVECs were later 
subcultured after reaching ca. 90% confluency and re-seeded again at 1 × 105 cells/well density to 6-well plates for 
Figure 6. Cellular stress response to long-term accumulation of AuNPs. RT-PCR analysis of an ER stress 
indicator (XBP1) in HUVECs at different AuNP accumulation time points following 10% polyacrylamide 
gel electrophoresis. The unspliced uXBP1 (289 bp) and spliced sXBP1 (263 bp) forms of XBP1 are indicated 
(A). qRT-PCR analysis of spliced XBP1 (sXBP1) in HUVECs at different accumulation time points, where 
expression of sXBP1 was normalized to GAPDH and AuNP (− ) samples. One way ANOVA with Dunnett’s 
Multiple Comparison test was used to show statistical significance at ***p < 0.001 (B). ROS levels were analyzed 
in AuNP (+ ) and AuNP (− ) cells after 57 days of accumulation by DCF assay (C) (Error bars show SEM, 
experiment was performed with n = 3. Student t test was applied for statistical analysis).
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further incubation. This process was repeated in three day intervals, as represented in Fig. 1. In each passage, the 
remaining cell pellets were used for RNA isolation, protein isolation, viability, and proliferation analyses, silver 
staining and ICP-MS measurements. For ICP-MS measurements, cells were counted at least three times with 
trypan blue to determine the remaining cell amounts for normalization.
Imaging of AuNPs within Cells by Silver Staining. HUVECs were seeded on 13 mm cover glasses at 
a density of 2.5 × 104 cells/glass. After 4 h of incubation, media were removed and replaced with media contain-
ing AuNPs at concentrations ranging from 0.5 μ g/mL to 64 μ g/mL, and the cells were incubated for 24 h. Cells 
were then washed three times with 1x PBS to remove excess AuNPs. After washing, cells were fixed with 4% 
paraformaldehyde for 15 min, and silver staining was performed using Sigma Silver Enhancer Kit according to 
the manufacturer’s instructions. Bright field images were taken after staining to visualize AuNP presence within 
cells. Silver staining in different long-term accumulation time point was also performed with identical protocol 
explained above.
Quantification of AuNPs within Cells by ICP-MS. To investigate protein corona effects on the inter-
nalization of AuNPs, short-term uptake of AuNPs in 5% FBS DMEM and 10% FBS DMEM was performed in 
HUVECs. The cells were seeded in 6 well plates at a density of 1 × 105 cells/well, and exposed to 8 μ g/mL AuNPs 
in 5% FBS DMEM and 10% FBS DMEM after their attachment to well surfaces (~4 h). After 4 h incubation with 
AuNPs, cells were washed three times with 1x PBS to remove excess AuNPs. After washing, cells were detached 
from the surfaces with trypsinization and collected with centrifugation at 2500 rpm for 5 min. The protein isola-
tion was performed according to instructions of M-PER® Mammalian Protein Extraction Kit (Thermo Scientific). 
Protein concentrations of samples were determined with Pierce™ BCA Protein Assay (Thermo Scientific). Then, 
samples were digested by aquaregia, and diluted in 2% nitric acid immediately prior to measurement. A five-point 
calibration curve was prepared in a gold concentration range of 1.25–20 ng/mL, and the quantification was per-
formed through linear regression of the measured intensity of the analyte and internal standard (Bi) versus the 
concentration of calibration standards. All results were reported in ppb or ppm of gold per sample. Gold meas-
urements were performed using a Thermo Scientific X Series 2 ICP-MS.
To investigate long-term accumulation of AuNPs in HUVECs over time, cells were counted at least three times 
with trypan blue after each passage to determine the remaining cell amounts for normalization. After that, all cell 
pellets were kept frozen until analysis, and before analysis they were thawed. The following procedure for ICP-MS 
measurement was performed same as mentioned above. The number of AuNPs per cell was calculated as:
ρ π ρ= = = =m r m mass of one AuNP density of gold r radius of one AuNP4
3
3
To obtain number of AuNP in each sample, total ppb determined by ICP-MS was divided to the mass of one 
AuNP. Total AuNP number was divided to cell number.
Imaging of HUVECs with Fluorescent Molecules for Endocytosis Analysis. At day 23 of long-term 
accumulation, HUVECs were seeded on 13 mm cover glasses at a density of 2.5 × 104 cells/glass. After 4 h of incu-
bation, media were removed and replaced with media containing 5 μ g/mL Alexa Fluor 488 conjugated Cholera 
toxin subunit B (recombinant), 100 μ g/mL Fluorescein conjugated Dextran (10000 MW) and 25 μ g/mL Alexa 
Fluor 488 conjugated Transferrin from human serum and the cells were incubated additional 4 h. Cells were then 
washed three times with 1x PBS to remove excess molecules. After washing, coverslips were closed on glass slides 
and immediately imaged with Zeiss LSM 510 Meta before cell death.
Quantification of AuNPs in Medium by ICP-MS for Exocytosis Analysis. During long-term accu-
mulation experiment, all media were collected for exocytosis analysis before AuNPs exposure to the cells. Briefly, 
HUVECs were seeded in 6 well plates at a density of 1 × 105 cells/well, and medium was collected for ICP-MS 
measurement and replaced with AuNPs containing medium after their attachment to well surfaces (~4 h). All 
collected medium samples were kept frozen until analysis, and the following procedure for ICP-MS measurement 
was performed same as mentioned above.
Determination of Cellular Internalization Pathway of AuNPs. Endocytosis inhibitors are often used 
to determine which endocytosis pathway plays a central role for cellular uptake of NPs50. The concentrations 
and treatment times of small molecule chemical inhibitors were optimized in a preliminary experiment to select 
the maximum non-toxic doses and treatment times. HUVECs were seeded at 2.5 × 104 cells/well density in 24 
well plates. After 4 h of incubation, cells were treated with chemical inhibitors at final concentrations of 2.5 mM 
amiloride, 100 μ g/mL nystatin and 2.5 μ g/mL chlorpromazine to inhibit specific pathways and to understand 
the internalization mechanism of AuNPs (Table S1). After 1 h incubation, the inhibitors were removed, and the 
cells were exposed to 8 μ g/mL AuNPs in 5% FBS DMEM. After 4 h incubation with AuNPs, cells washed three 
times with 1x PBS to remove excess AuNPs. After washing, cells were detached from the surfaces with trypsin-
ization and collected with centrifugation at 2500 rpm for 5 min. The protein isolation was performed according 
to instructions of M-PER® Mammalian Protein Extraction Kit (Thermo Scientific). After that protein concentra-
tions of samples were determined with Pierce™ BCA Protein Assay (Thermo Scientific). Then, ICP-MS measure-
ment was performed same as mentioned above.
Determination of Cellular Stress Levels by qRT-PCR and Dichlorofluorescein assay. RT-PCR 
and qRT-PCR were used to quantify XBP1 and sXBP1 amounts. Total RNA was isolated from remaining cell pel-
lets using TRIzol (Invitrogen) according to manufacturer’s instructions. Nanodrop 2000 (Thermo Scientific) was 
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used to assess the yield and purity of extracted RNA. Primer sequences are listed in Table S2. Reaction efficiencies 
for each primer set were evaluated with standard curves using 2-fold serial dilutions of total RNA. cDNA synthe-
sis from RNA and RT-PCR were performed using SuperScript III One-Step RT-PCR Kit (Invitrogen) according to 
manufacturer’s instructions. PCR products of XBP1 were electrophoresed on 10% PAGE at 80 V for 5 h. The size 
difference between spliced and unspliced XBP1 is 26 nucleotides. sXBP1 gene expression profiles were analyzed 
at each time point of accumulation. Reaction conditions were briefly as follows: 55 °C for 5 min, 95 °C for 5 min, 
40 cycles of 95 °C for 15 s, 60 °C for 30 s, and 40 °C for 1 min, followed by a melting curve to confirm product spec-
ificity. For gene expression analysis a comparative Ct method was used with formula of (primer efficiency)−ΔΔCt 
where Δ Δ Ct and Δ Ct were explained as:
∆∆ ∆ ∆ ∆= + − − = −Ct Ct AuNP Ct AuNP and Ct Ct sXBP Ct GAPDH( ( )) ( ( )) ( 1) ( )
Reactive oxygen species (ROS) formation was analyzed with Dichlorofluorescein (DCF) assay after 57 days 
of accumulation.
Statistical Analysis. All experiments were independently repeated at least twice, with at least four repli-
cas for each experimental or control group in each independent assay. All quantitative results were expressed 
as means ± SEM. Statistical analyses were carried out by one-way analysis of variance (ANOVA) or Student’s t 
test, whichever applicable. Degrees of significance are indicated in graphs when necessary (*p < 0.05; **p < 0.01; 
***p < 0.001).
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